Cloud Computing Market Poised to Expand at a Robust Pace Over 2030: Grand View Research Inc.

 Cloud Computing Market Growth & Trends

The global cloud computing market size is expected to reach USD 1,554.94 billion by 2030, registering a CAGR of 14.1% from 2023 to 2030, according to a new study conducted by Grand View Research, Inc. The main factors driving the market growth include the rising adoption of cloud-native applications by several business sectors, such as banking and supply chain automation. In addition, they allow businesses to develop, manage, and roll out web applications quickly. For instance, in June 2022, Redington, a technology products and services provider, partnered with Amazon Web Services, Inc. to promote the adoption of cloud computing in India. The partnership helps the former company to enhance cloud capabilities within existing markets and allows it to expand its reach into Tier 2 and 3 locations.

Increased adoption of advanced and innovative technologies, such as Artificial Intelligence (AI), Machine Learning (ML), and 5G technologies, and their rapid implementation within business applications is anticipated to drive market growth. Since the COVID-19 outbreak, technological advancements have accelerated rapidly. Enterprises can now efficiently store, access, and manage vital data owing to cloud computing technologies. With the increasing use of smartphones, computers, and the internet, businesses now need to store and process enormous amounts of data to provide their consumers and clients with services centered on their needs. This is attributed to the rise in demand for cloud computing. Machine learning, edge computing, and personalization is currently significant trend across several businesses.

To perform the complicated computations frequently required for personalization, such as to generate tailored suggestions, the cloud lowers the technological barriers associated with doing so. For instance, in October 2022, Oracle launched Oracle Alloy, a cloud infrastructure platform that allows service providers, installers, Independent Software Suppliers (ISVs), and other businesses, such as financial institutions or telecom providers. With Alloy, these businesses can provide a comprehensive range of cloud services, brand and customize the user experience, and package extra value-added offerings and apps to cater to the unique requirements of their markets and industry sectors. Vendors are focusing on launching new cloud solutions, services, & workloads, and enhancing the capabilities of their current ones to gain higher market share.

Companies often use strategies, such as mergers and acquisitions, to improve their industry position and cloud capabilities. For instance, in November 2022, Laminar, a cloud security services provider, announced a partnership with Amazon Web Services, Inc. with the expansion of the AWS Partner Network and the broad availability of its Cloud Data Security Platform on the AWS Marketplace. The AWS Marketplace is a retail website that customers may use to locate, purchase, deploy, and control third-party software, resources, and services for business solutions and to operate their businesses on AWS. The collaboration aims to make it simple for shared customers to use and access our cloud data security solutions at a time when Laminar is experiencing substantial growth.

Request a free sample copy or view the report summary: Cloud Computing Market Report

Cloud Computing Market Report Highlights

• The Infrastructure as a Service segment is expected to register the highest CAGR from 20230 to 2030 owing to the rising IaaS adoption, which is fueled by the growing need to simplify IT complexities, find qualified workers to manage IT infrastructures, and lower the cost of deploying data centers
• The small- and medium-sized business segment is expected to grow at the highest CAGR from 2023 to 2030 due to lower prices for IT software and hardware, increased processing power and storage elasticity, and increased mobility in accessing data and services. Over the forecast period, the industry growth is likely to be driven by the rising usage of cloud technology across SMEs in developing regions
• The hybrid deployment segment is anticipated to register the fastest CAGR from 2023 to 2030. To improve their cost optimization, business model, application development, operational efficiency, and user experience, industries are increasingly adopting hybrid models
• In the coming years, it is anticipated that the rapid adoption of edge computing will increase demand among companies worldwide for hybrid clouds
• The manufacturing end-use segment is expected to register the highest growth rate from 2023 to 2030 due to its advantages, such as seamless data management and real-time visibility. The manufacturing industry’s increasing use of cloud services for data storage, managing the supply chain, and organizing enterprise resources is anticipated to fuel the segment's growth over the forecasted period
• Asia Pacific is anticipated to experience the fastest CAGR from 2023 to 2030 due to SMEs and the increased attention of large-scale businesses on enhancing their digital activities

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cloud-computing-market

Cloud Computing Market Segmentation

Grand View Research has segmented the global cloud computing market based on service, deployment, enterprise size, end-use, and region:

Cloud Computing Service Outlook (Revenue, USD Billion, 2018 - 2030)

• Infrastructure As A Service (IaaS)
• Platform As A Service (PaaS)
• Software As A Service (SaaS)

Cloud Computing Deployment Outlook (Revenue, USD Billion, 2018 - 2030)

• Public
• Private
• Hybrid

Cloud Computing Enterprise Size Outlook (Revenue, USD Billion, 2018 - 2030)

• Large Enterprises
• Small & Medium Enterprises (SMEs)

Cloud Computing End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• BFSI
• IT & Telecom
• Retail & Consumer Goods
• Manufacturing
• Energy & Utilities
• Healthcare
• Media & Entertainment
• Government & Public Sector
• Others

Cloud Computing Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)

List of Key Players in the Cloud Computing Market

• Adobe Inc.
• Alibaba Group Holding Ltd.
• com Inc.
• Cisco Systems, Inc.
• Dell Inc.
• Google LLC (Alphabet Inc.)
• Hewlett Packard Enterprise Development LP
• International Business Machines Corp.
• Microsoft Corp.
• Oracle Corp.
• com Inc.
• SAP SE
• Workday, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

IT Asset Disposition Market Latest Trends, Industry Growth And Forecast To 2030: Grand View Research Inc.

 IT Asset Disposition Market Growth & Trends

The global IT asset disposition market size is projected to be USD 54,535.4 million by 2030, according to the latest study conducted by Grand View Research, Inc. The market is expected to exhibit a CAGR of 13.3% from 2023 to 2030. The growth of the ITAD market can be attributed to the increasing e-waste and the rising requirement for recycling in consideration of sustainability and a green planet.

For instance, according to the Indian Ministry of Electronics and Information Technology, India generated 3.2 million tonnes of electronic waste in 2019, and only 10% of e-waste was taken up for recycling. Such an alarming figure has resulted in the demand for ITAD solutions, thereby driving the market’s growth.

Various companies have been coming up with ITAD solutions with enhanced capabilities, which can serve multiple industries. Moreover, companies operating in the ITAD market have also been involved in various strategic initiatives and R&D, among others, to improve their share in the ITAD market. For instance, in January 2023, ERI announced that it had become 100% carbon neutral for all its operational emissions across the U.S.

The company achieved this by implementing carbon-reducing measures such as energy-efficient lighting, using zero-emission vehicles, fleet management, and using electric forklifts, among others. 100% Carbon neutrality would help the company better position in the ITAD market, which would thereby help in driving the growth of the ITAD market over the forecast period.

Cloud transition is another significant aspect that has been pivotal in driving the growth of the IT asset disposition industry over the forecast period. Cloud migration's benefits include increased flexibility and agility, reduced costs, enhanced cybersecurity, simplified management, and disaster recovery. All these attributes have made it a go-to area for businesses operating in various industries.

Moreover, the presence of ITAD solution providers in the market who are equipped to assist in cloud migration services and ITAD has been a significant boost to the growth of the IT asset disposition industry. For instance, Apto Solutions Inc. offers cloud migration services, in which the company handles the existing hardware for carrying out the following operations.

• Data destruction
• Asset inventory
• Logistics to one of the company’s certified facilities

Post carrying out these operations, the company either sells or recycles the hardware component. The presence of companies that offers a total solution, as in the case of Apto Solutions Inc., has been a significant boon to the growth of the IT asset disposition industry.

Request a free sample copy or view report summary: IT Asset Disposition Market Report

IT Asset Disposition Market Report Highlights

• The computers/laptops segment is expected to occupy the largest revenue share by asset type in 2030. The growth can be attributed to digitalization, especially in low-income countries, and rising internet users, among others
• The smartphone segment is expected to witness the highest CAGR by asset type during the forecast period. The growth can be attributed to increased smartphone sales, increasing internet penetration, and smartphones coming up with enhanced smartphones quite often, among others
• The IT & telecom industry is expected to occupy the largest share of the market in terms of end-use by 2030, owing to an increase in internet users, adoption of 5G technology, and increased demand for connectivity worldwide, among others
• Asia Pacific is projected to witness the highest CAGR from 2023 to 2030. The region is home to some tech giants such as Samsung, Sony Corporation, and LG electronics, among others. Moreover, the increasing digitalization in countries such as Indonesia, Vietnam, and Bangladesh is another factor contributing to the growth of the Asia Pacific region
• Global players include Apto Solutions Inc.; Dell Inc.; IBM Corporation; and Iron Mountain. These major players are embracing organic and inorganic growth strategies, which include product innovation, investments in R&D, and M&A activities to acquire a larger industry share

Access Press Release@ https://www.grandviewresearch.com/press-release/global-it-asset-disposition-market

IT Asset Disposition Market Segmentation

Grand View Research has segmented the global IT asset disposition market based on asset type, end-use, and region:

IT Asset Disposition Asset Type Outlook (Revenue; USD Billion, 2018 - 2030)

• Computers/Laptops
• Smartphones and Tablets
• Peripherals
• Storages
• Servers
• Others

IT Asset Disposition End-use Outlook (Revenue; USD Billion, 2018 - 2030)

• BFSI
• IT & Telecom
• Government
• Energy and Utilities
• Healthcare
• Media and Entertainment
• Others

IT Asset Disposition Regional Outlook (Revenue; USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Singapore
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa

List of Key Players in the IT Asset Disposition Market

• Apto Solutions Inc.
• CompuCom Systems, Inc.
• Dell Inc.
• Hewlett Packard Enterprise Development LP
• IBM Corporation
• Ingram Micro Services
• Iron Mountain
• ITRenew
• LifeSpan International Inc.
• Sims Lifecycle Services, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Testing, Inspection, And Certification Market Set to Surge Significantly During 2023-2030: Grand View Research Inc.

 Testing, Inspection, And Certification Market Growth & Trends

The global testing, inspection, and certification market size is anticipated to reach USD 499.0 billion by 2030, growing at a CAGR of 4.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. The incremental deployment rates of testing, inspection, and certification (TIC) systems and solutions can be accredited to the rise in manufacturing activities worldwide. Furthermore, the onset of Industry 5.0 and the rise in connected systems further augments the need to deploy TIC-based technologies in tandem with manufacturing activities.

The need to optimize manufacturing processes and end products has resulted in the manufacturing application segment capturing the highest growth rate of 6.4% over the forecast period. For instance, in January 2022, SGS, a Swiss international business that provides inspection, verification, testing, and certification services, has launched a new Vehicle Over the Air (OTA) performance testing laboratory in Suzhou, China. The lab will assist automotive manufacturers in helping them test, validate, and comply with evolving wireless standards and regulations. It fully integrates beneficial resources in automobile, communication, electronics, and reliability testing to provide commercial customers with technical verification, quality improvement product certification, and technology development services.

The integration of cloud technology with the TIC market is one of the significant market drivers. The need to access data instantly, automate certification, and issue reports on a real-time basis highlights the importance of storing essential TIC-related data in the cloud. Moreover, cybersecurity concerns such as increasing instances of cyberattack and data privacy threats further highlight the importance of a safe cloud architecture to safeguard data from people with malicious intent.

This is expected to help in general data regulation, security certifications, and software testing. For instance, in February 2022, Intertek Group plc, one of the prominent providers in connectivity testing and cybersecurity, established its Acucert, the first ISO/IEC certified cybersecurity testing lab in Mumbai, India. Acucert has significant expertise in IT system and software testing while meeting stringent quality control standards. Further opening a new testing lab would help them promote internationally and nationally.

The gradual acceptance of big data analytics with the TIC-based technology model is also expected to offer an impetus to the TIC market. The adoption of big data analytics technology by service providers is expected to diversify their service offerings, such as data-based services and predictive maintenance data and enable service providers to offer better solutions to their customers.

In September 2021, TÜV SÜD, a safety, security, and sustainability solutions provider, offered wind turbine certification for areas affected by tropical storms. Within the scope of type certification, the company has designed a computer framework to analyze the data of the areas and check compatibility for these regions based on the worldwide IEC 61400 standard. The computer model allows for the simulation of even the most extreme wind conditions in tropical cyclone-prone areas and the use of this simulation to determine if a wind turbine is suited for such places.

Asia Pacific is expected to capture the highest growth rate over the forecast period. Rapid industrialization and rising infrastructure development in Australia, South Korea, and India facilitate deploying proficient TIC solutions. Furthermore, the emerging technology ecosystem in countries such as Japan and China have resulted in several companies outsourcing their software and product development tasks. The ability to gain high-performance products at affordable rates from these countries promotes companies to access TIC solutions and services related to specific needs and requirements, thereby offering an impetus to market growth.

In December 2021, Eurofins Scientific, a global scientific leader in bioanalytical testing and a clinical diagnostic testing leader with Transgenic Inc., announced the acquisition of GeneticLab Co., Ltd., a molecular biology-based testing vendor. This acquisition will assist the company in strengthening its position in the Japanese market. It would further expand the company’s global presence in Asia, specializing in advanced genetic testing.

Request a free sample copy or view report summary: Testing, Inspection, And Certification Market Report

Testing, Inspection, And Certification Market Report Highlights

• The certification segment is expected to emerge as the fastest-growing segment over the forecast period. The segmental growth can be attributed to increasing need of companies to certify their business practices use the right talent for specialized work.
• The outsourced segment is expected to register the highest CAGR over the forecast period owing to the ability to access more affordable TIC products and solutions and decreased operational expenditure.
• The manufacturing segment is expected to capture the highest growth rate over the forecast period owing to rising industrial activity around the world and development of new machine components which need to be tested and inspected before deployment.
• Asia Pacific region is expected to dominate the market over the forecast period. This can be attributed to rising economic activity in China and India. The implementation of Bharat Stage 6 in India has led automotive developers to develop new automotive components which have to be tested rigorously to meet international standards.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-tic-market

Testing, Inspection, And Certification Market Segmentation

Grand View Research has segmented the global testing, inspection, and certification market report based on service type, sourcing type, application, and region:

Testing, Inspection, And Certification Service Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Testing
• Inspection
• Certification

Testing, Inspection, And Certification Sourcing Type Outlook (Revenue, USD Billion, 2017 - 2030)

• In-house
• Outsourced

Testing, Inspection, And Certification Application Outlook (Revenue, USD Billion, 2017 - 2030)

• Consumer Goods & Retail
• Agriculture & Food
• Chemicals
• Infrastructure
• Energy & Power
• Education
• Government
• Manufacturing
• Healthcare
• Mining
• Oil & Gas And Petroleum
• Public Sector
• Automotive
• Aerospace & Defense
• Supply Chain & Logistics
• Others

Testing, Inspection, And Certification Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• South America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE

List of Key Players of Testing, Inspection, And Certification (TIC) Market

• ALS Limited
• Applus+
• Bureau Veritas SA
• DEKRA SE
• DNV GL
• Element Materials Technology
• Eurofins Scientific
• Intertek Group plc
• MISTRAS Group, Inc.
• SGS SA
• TÜV NORD GROUP
• TÜV Rheinland
• TÜV SÜD
• UL LLC.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Smart Home Market Revenue is Expected to Reach USD 537.01 Billion by 2030: Grand View Research Inc.

 Smart Home Market Growth & Trends

The global smart home market size is expected to reach USD 537.01 billion by 2030, registering a CAGR of 27.07% from 2023 to 2030, according to a new study by Grand View Research, Inc. The smart home is driven by computing devices and information technology that link smart home instruments and gadgets to provide convenience, entertainment, and enhanced comfort to residents in a sustainable way. The market growth is attributed to the rising penetration of the Internet of Things (IoT) and Internet connectivity in homes. Moreover, the trend of modern technologies, such as Artificial Intelligence (AI), being integrated with smart homes has enabled more advanced and digitally smart devices for better living.

In addition, the growing penetration of smartphones is driving the market as smart home devices can be controlled through a smartphone, thereby enabling ease of access and usage. Furthermore, the trend of automation in daily mundane tasks is expected to support market growth significantly. The rising need for home security has prompted the use of AI-powered smart home devices. Facial recognition and threat analysis are among the features included in these gadgets that are expected to drive the demand for smart home solutions. Asia Pacific is expected to emerge as the fastest-growing region over the forecast period.

This is mainly owing to the improved standards of living and increased consumer disposable income levels in the region. The rapid penetration of the internet, smartphones, and other digitally advanced equipment in the region is also expected to drive market growth. Furthermore, the increased demand for smart speakers, such as Siri and Alexa, significantly impacts the region’s growth. In addition, the trend of luxurious lifestyles in developing nations in the region, due to increased disposable income and personal choice among consumers for smart devices, is propelling the market growth.

Request a free sample copy or view report summary: Smart Home Market Report

Smart Home Market Highlights

• Based on products, the security & access controls segment recorded the highest revenue share in 2022 due to the increased demand for advanced security solutions and the necessity to restrict access to rooms or safes with valuable items and goods
• The wireless protocols segment is expected to grow at the highest CAGR over the forecast period as wireless technology is continuously undergoing extreme developments in terms of connectivity and latency
• The new construction application segment is expected to register the fastest CAGR over the forecast period as product installations are easier in new constructions with prior knowledge of wall placements and wire/power outlets
• The Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period due to the increasing internet and IoT devices penetration

Access Press Release@ https://www.grandviewresearch.com/press-release/global-smart-homes-market

Smart Home Market Segmentation

Grand View Research has segmented the global smart home market on the basis of products, protocols, application, and region:

Smart Home Products Outlook (Revenue, USD Million, 2018 - 2030)

• Security & Access Controls
  • Security Cameras
  • Video Door Phones
  • Smart Locks
  • Remote Monitoring Software & Services
  • Others
• Lighting Control
  • Smart Lights
  • Relays & Switches
  • Occupancy Sensors
  • Dimmers
  • Other Products
• Entertainment Devices
  • Smart Displays/TV
  • Streaming Devices
  • Sound Bars & Speakers
• HVAC
  • Smart Thermostats
  • Sensors
  • Smart Vents
  • Others
• Smart Kitchen Appliances
  • Refrigerators
  • Dish Washers
  • Cooktops
  • Microwave/Ovens
• Home Appliances
  • Smart Washing Machines
  • Smart Water Heaters
  • Smart Vacuum Cleaners
• Smart Furniture
• Home Healthcare
• Other Devices

Smart Home Protocols Outlook (Revenue, USD Million, 2018 - 2030)

• Wireless Protocols
  • ZigBee
  • Wi-Fi
  • Bluetooth
  • Z Wave
  • Others
• Wired Protocols
• Hybrid

Smart Home Application Outlook (Revenue, USD Million, 2018 - 2030)

• New Construction
• Retrofit

Smart Home Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Benelux
  • Nordic Countries
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Nigeria

List of Key Players of Smart Home Market

• LG Electronics, Inc.
• Siemens AG
• com, Inc.
• Google Nest (Google LLC)
• Samsung Electronics Co. Ltd.
• Schneider Electric SE
• Legrand S.A.
• Robert Bosch GmbH
• Assa Abloy AB
• Sony Group Corporation
• ABB, Ltd.
• Philips Lighting B.V.
• Honeywell International, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Plasma Fractionation Market Expected to Witness a Sustainable Growth over 2030: Grand View Research Inc.

 Plasma Fractionation Market Growth & Trends

The global plasma fractionation market is expected to reach USD 58.24 billion by 2030, expanding at a CAGR of 8.3%, according to a new report by Grand View Research, Inc. The major factors driving the market growth are the rising prevalence of respiratory illnesses globally, blood-related diseases, and an aging population that is prone to a variety of rare disorders. These are the main drivers of market expansion. In addition, the rise in the prevalence of rare disorders that call for plasma therapy or derivatives also supplemented the market growth.

Plasma Fractionation Market Report Scope 

Report Attribute	Details
Market size value in 2022	USD 30.71 billion
Revenue forecast in 2030	USD 58.24 billion
Growth rate	CAGR of 8.3% from 2022 to 2030
Base year for estimation	2021
Historical data	2018 - 2020
Forecast period	2022 - 2030

The global market is also expanding due to the increased use of immunoglobulins as well as alpha-1-antitrypsin in various areas of research around the world. Another important factor for the expansion of the market is the rise in blood collection facilities globally. For instance, as per the WHO, as of May 2022, over 118 million blood donations were collected across the globe, thus increasing the plasma supply gradually. Additionally, supportive government initiatives to raise public awareness about the usage of plasma-derived products also serve as a major driver of the global market's expansion.

Blood plasma transfusions are one of the cutting-edge treatments for COVID-19 infection. For instance, in August 2020, the US Food and Drug Administration (USFDA) granted the convalescent plasma treatment of COVID-19 an emergency use authorization (EUA). Additionally, in February 2021, it published an amended directive for the plasma EUA for COVID-19. As a result, the usage of plasma fractionation technologies is projected to increase during the COVID-19 pandemic.

The growing demand for personalized medications has increased R&D spending, and technological advancements in plasma components such as immune serum globulin, which have advantages such as higher yield, lower cost, and faster throughput, are driving market growth. On the other hand, immunoglobulins generated from plasma are being employed more frequently for a variety of clinical conditions, including autoimmune and inflammatory illnesses. Therapies including Ceruloplasmin, IgA, and Plasmin have received significant funding from the plasma fractionation sector. Additionally, the industry will receive a boost from booming investments in innovation and technology developments that result in efficient and affordable methods for fractionating proteins. thus, propelling the market's growth.

For companies operating market-related businesses, the market offers a lot of opportunities. In addition, the global and regional market participants are actively implementing organic and inorganic development strategies as a result of the market's favorable expansion. As a result, it is anticipated that the market will draw more notable investments during the forecast period. For instance, in January 2022, the eighth plasma collection facility in the Czech Republic was opened by Biotest AG. The national public health authority, SUKL, granted the company an operating license for these centers.

Request a free sample copy or view report summary: Plasma Fractionation Market Report

Plasma Fractionation Market Report Highlights

• By product, the immunoglobulins segment held the largest share in 2021. This is anticipated to be driven by rising research activities and the growing demand for immunoglobulin for the treatment of various neurological diseases such as dementia, Alzheimer's, and others
• By application, the neurology segment accounted for the largest share in 2021. This is attributed to the growing demand for efficient neurovascular treatments fueled by the rising prevalence of patients with neurovascular diseases such as cerebral aneurysms, brain stroke, and epilepsy
• By the method, the centrifugation segment held a larger share in 2021. The treatment and diagnostic procedures of numerous chronic and infectious diseases become more complex. For these purposes, the use of modern laboratory centrifuges is becoming a crucial method
• By end-use, the hospitals & clinics segment held a larger share in 2021. The hospitals & clinics are using plasma-derived products more frequently to treat autoimmune disorders like type 1 diabetes, as well as the improved infrastructure and healthcare facilities, augment the market growth
• North America held the larger share in 2021. This is due to the region's advanced healthcare facilities and favorable governmental policies, which are expected to increase demand for the product
• The Asia Pacific is expected to grow at the highest rate in a projected time. Driven by factors such as the rising prevalence of target diseases with an aging population, rising plasma-based therapeutics adoption, and others

Access Press Release@ https://www.grandviewresearch.com/press-release/global-plasma-fractionation-market

Plasma Fractionation Market Segmentation

Grand View Research has segmented the global plasma fractionation market based on product, application, method, end-use, and region:

Product Scope Outlook (Revenue, USD Million, 2018 - 2030)

• Albumin
• Immunoglobulins
  • Intravenous immunoglobulins
  • Subcutaneous immunoglobulins
  • Others
• Coagulation Factors
  • Factor VIII
  • Factor IX
  • VON WILLEBRAND factor
  • Prothrombin complex concentrates
  • Fibrinogen concentrates
  • Others
• Protease inhibitors
• Others

Method Scope Outlook (Revenue, USD Million, 2018 - 2030)

• Centrifugation
• Depth Filtration
• Chromatography
• Others

Application Scope Outlook (Revenue, USD Million, 2018 - 2030)

• Neurology
• Hematology
• Oncology
• Immunology
• Pulmonology
• Others

End-Use Scope Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Clinics
• Clinical Research
• Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Plasma Fractionation Market

• Grifols S.A.
• CSL Limited
• Takeda Pharmaceutical Company Limited
• Octapharma AG
• Kedrion S.p.A
• LFB S.A.
• Biotest AG
• Sanquin
• Bio Products Laboratory Ltd.
• Intas Pharmaceuticals Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Non-alcoholic Steatohepatitis Treatment Market Growth With Worldwide Industry Analysis To 2030: Grand View Research Inc.

 Non-Alcoholic Steatohepatitis Treatment Market Growth & Trends

The global non-alcoholic steatohepatitis treatment market size is expected to reach USD 15.95 billion by 2030, according to a new report by Grand View Research, Inc. The industry is projected to expand at a CAGR of 39.2% from 2022 to 2030. The non-alcoholic steatohepatitis (NASH) treatment market is primarily driven by the launch of drugs such as Novo Nordisk's Ozempic, Intercept's Ocaliva, and Inventiva's lanifibranor, among others.

The NASH treatment market has major unmet needs owing to factors such as the unavailability of approved drugs, high disease burden, and complex diagnostic procedures. Currently, the market is dominated by off-label drugs such as Pioglitazone and Vitamin E. These are widely prescribed drugs in this space globally. However, to address the unmet opportunity, key market players are heavily investing in R&D activities to develop novel therapeutics for NASH treatment. Currently, there are more than 50 pipeline candidates.

Non-Alcoholic Steatohepatitis Treatment Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 1.13 billion
Revenue forecast in 2030	USD 15.95 billion
Growth rate	CAGR of 39.2% from 2022 to 2030
Base year for estimation	2021
Historical data	2018 - 2020
Forecast period	2022 - 2030

Some of the late-stage pipeline candidates expected to launch during the forecast period include Inventiva Pharma's Lanifibranor, Intercept Pharmaceuticals' Obeticholic acid, Galmed Pharmaceuticals Ltd.'s Aramchol, Novo Nordisk A/S's Semaglutide, and Madrigal Pharmaceuticals, Inc.'s Resmetirom. Among these, Intercept Pharmaceuticals's Obeticholic Acid (OCA), and Madrigal Pharmaceuticals, Inc.'s Resmetirom, are the most looked upon drugs and are expected to enter comparatively earlier than other pipeline candidates.

Research studies reveal that non-alcoholic steatohepatitis is strongly associated with obesity and diabetes. Research studies show that around 80% of NASH patients are obese. In countries such as the U.S., the obesity prevalence is as high as 42%, according to the latest 2021 statistics by CDC. In addition, countries such as the U.S. and Japan account for the highest prevalence of non-alcoholic steatohepatitis globally, and these countries also have a high burden of obesity and diabetes. All such factors will fuel the NASH treatment market throughout the forecast period.

Strategic initiatives by pharma giants and supportive regulatory authority policies such as fast track designation are further expected to accelerate the market growth. In May 2022, Pfizer, Inc.'s Ervogastat/Clesacostat Combination therapy received fast track designation. This is one of the potential drug combinations for the treatment of non-alcoholic steatohepatitis. Such drug designation boosts the clinical trial process for drugs.

Liver biopsy is the gold standard for the diagnosis of non-alcoholic steatohepatitis. The invasive nature of this diagnostics test limits its usage to only symptomatic cases, and as a result, the global average diagnostic rate for NASH is around 20%. The unavailability of biomarkers-based non-invasive tests for the diagnosis of non-alcoholic steatohepatitis is expected to impede the market growth.

Request a free sample copy or view report summary: Non-Alcoholic Steatohepatitis Treatment Market Report

Non-Alcoholic Steatohepatitis Treatment Market Report Highlights

• Vitamin E and Pioglitazone (Off-label) acted as the lone contributor with a 100% share of the market in 2021. This can be attributed to the unavailability of approved drugs in the market
• The retail and specialty pharmacies segment held a share of 63.8% in 2021. Retail and specialty pharmacies are more compatible with chronic diseases such as NASH, where the patients are more commonly associated with homecare settings
• North America dominated the overall NASH treatment space in terms of revenue. This can be attributed to increased disease awareness, better healthcare facilities, and comparatively higher treatment rate than in other regions

Access Press Release@ https://www.grandviewresearch.com/press-release/global-non-alcoholic-steatohepatitis-nash-treatment-market

Non-Alcoholic Steatohepatitis Treatment Market Segmentation

Grand View Research has segmented the global non-alcoholic steatohepatitis treatment market based on drug type, end-use, and region:

NASH Treatment Drug Type Outlook (Revenue, USD Million, 2018 - 2030)

• Vitamin E and Pioglitazone
• Obeticholic Acid (OCA)
• Lanifibranor
• Semaglutide
• Resmetirom
• Aramchol
• Cenicriviroc
• Others

NASH Treatment End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacies
• Retail & Specialty Pharmacies
• Others

NASH Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Non-alcoholic Steatohepatitis (NASH) Treatment Market

• Intercept Pharmaceuticals
• Galmed Pharmaceuticals
• Inventiva Pharma
• AbbVie Inc.
• Galectin Therapeutics Inc.
• Madrigal Pharmaceuticals
• NGM Biopharmaceuticals Inc.
• Novo Nordisk A/S
• Bristol Myers Squibb
• Gilead Sciences, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Rare Diseases Treatment Market to Reach Around USD 335.84 Billion by 2030: Grand View Research Inc.

 Rare Diseases Treatment Market Growth & Trends 

The global rare diseases treatment market size is expected to reach USD 335.84 billion by 2030, according to a new study by Grand View Research Inc., expanding at a CAGR of 12.8% from 2022 to 2030. Increasing prevalence of rare diseases contributes to industry growth. According to the National Center for Advancing Translational Sciences (NCATS), over 30 million of the U.S. population is estimated to be affected by rare diseases in 2022. Increasing prevalence of people living with orphan diseases is anticipated to increase the sales and demand for orphan medicines over the forecast period. 

The presence of supportive regulations by government authorities, such as the Orphan Drug Act that support product development by offering the orphan drug designation to potential drug candidates developed by pharmaceutical companies, is expected to support industry growth. This initiative boosts the research and development in the field of orphan disease treatment. 

Rare Diseases Treatment Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 128.42 billion
Revenue forecast in 2030	USD 335.84 billion
Growth rate	CAGR of 12.8% from 2022 to 2030
Base year for estimation	2021
Historical data	2018 - 2020
Forecast period	2022 - 2030

In April 2020, the National Organization for Rare Disorders (NORD) launched the “COVID-19 critical relief” program for patients with rare diseases affected by the COVID-19 pandemic. Under this program, the NORD provided monetary assistance of up to USD 1,000 annually to orphan disease patients and their caregivers for fulfilling their medical and non-medical needs. Thus, the availability of such programs is anticipated to boost the adoption of rare disease treatment over the forecast period. 

Moreover, companies have undertaken initiatives such as collaborations and partnerships for the development, manufacturing, and commercialization of products in the international market. For instance, in August 2020, Sarepta Therapeutics, Inc. entered into a collaboration with the University of Florida for the development of novel genetic medicines for the treatment of patients with various orphan diseases, including Duchenne Muscular Dystrophy (DMD). 

However, a lack of accurate and early diagnosis of rare diseases can often present a challenge for orphan disease patients, and in some cases, an accurate diagnosis is not obtained for as long as five years. In addition, patient eligibility and recruitment of eligible patients for clinical trials for rare disease treatment may restrain the industry growth. Not only finding the target population is difficult but finding physicians who treat these patients is also complex, thus leading to delays in the new product approval and launch in the market. 

Request a free sample copy or view report summary: Rare Diseases Treatment Market Report

Rare Diseases Treatment Market Report Highlights

• By therapeutic area, cancer segment held the largest revenue share in 2021 due to high prevalence of cancer indications such as multiple myeloma, acute lymphoblastic leukemia, chronic myeloid leukemia, and esophageal cancer and wide availability of orphan drugs for the treatment of patients with these conditions
• By route of administration, the injectable segment dominated the market in 2021 and is expected to witness significant growth owing to high safety, efficacy, and tolerability associated with this route of administration among rare disease patients
• By drug type, the biologics segment dominated the market in 2021 due to the presence of supportive reimbursement policies and the higher efficacy of biologics as disease-modifying therapies for the treatment of rare diseases
• By distribution channel, the specialty pharmacy segment dominated the market in 2021 due to government initiatives to support specialty pharmacies that provide orphan drugs. For instance, in July 2022, Utilization Review Accreditation Commission (URAC) awarded Maxor Specialty Pharmacy with the rare diseases pharmacy center of excellence for providing high-quality orphan drugs to patients
• Asia Pacific is expected to witness lucrative growth during the forecast period. The growth of the region can be attributed to the entry of new products into the region. According to Illness Challenged Foundation, China had approved new 87 orphan drugs for 47 rare diseases by the end of 2021 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-rare-diseases-treatment-market

Rare Diseases Treatment Market Segmentation 

Grand View Research has segmented the global rare diseases treatment market by therapeutic area, route of administration, drug type, distribution channel, and region: 

Rare Diseases Treatment Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

• Cancer
• Neurological Conditions
• Cardiovascular Conditions
• Musculoskeletal Conditions
• Hematologic Disorders
• Infectious Diseases
• Metabolic Disorders
• Endocrine Disorders
• Others

Rare Diseases Treatment Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral
• Injectable
• Others

Rare Diseases Treatment Drug Type Outlook (Revenue, USD Million, 2018 - 2030)

• Biologics
• Biosimilar
• Small Molecule

Rare Diseases Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacy
• Specialty Pharmacy
• Online Pharmacy

Rare Diseases Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Brazil
• Latin America
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Rare Diseases Treatment Market

• Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• PTC Therapeutics
• AstraZeneca
• Novartis AG
• Takeda Pharmaceutical Company
• Bayer AG
• AbbVie Inc.
• Merck & Co. Inc.
• Bristol Myers Squibb

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Energy-based Aesthetic Devices Market Estimated To Flourish By 2030: Grand View Research Inc.

 Energy-based Aesthetic Devices Market Growth & Trends

The global energy-based aesthetic devices market size is expected to reach USD 15.9 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 13.8% from 2022 to 2030. The rise in public awareness regarding medical aesthetics, an increase in the obese population, technological advancements in energy-based aesthetic devices, and rise in the number of medspas and surgical centers across the globe are the key factors that boost the growth of the market. The demand for energy-based aesthetic devices is projected to witness a rise during the forecast period due to the high preference among people for body contouring and skin tightening procedures.

The COVID-19 pandemic had disrupted a number of aesthetic procedures due to the restrictions imposed by the government. Also, the COVID-19 pandemic has negatively impacted the aesthetics industry. According to Allure, dermatology procedures will be slow to get a reboot during and after the pandemic due to safety concerns and infection control. However, in 2021, there was no significant impact on the market as medspa, traditional spa, and surgical centers were reopened in many countries and the number of aesthetic procedures also increased.

The rise in public preference for minimally invasive beauty treatments, demand for fat reduction and body shaping due to the rise in the obese population, surge in R&D activities along with the launch of new energy-based aesthetic devices, and increasing healthcare expenditure are the major factors that drive the market. In addition, the rise in the adoption of energy-based aesthetic devices has surged the focus of players on developing less-expensive and easy-to-use aesthetic products. Moreover, well-established reimbursement policies and strong medical infrastructure in developed countries further boost the growth of the market.

Request a free sample copy or view report summary: Energy-based Aesthetic Devices Market Report

Energy-based Aesthetic Devices Market Report Highlights

• The body contouring and skin tightening segment emerged as the largest application segment in 2021 with a revenue share of over 20.0% due to rapid surge in the need among the young population to appear flawless
• By end-use, the medspa segment accounted for the largest revenue share in 2021 and is expected to witness the highest growth over the forecast period due to an increase in demand for minimally invasive aesthetic treatment procedures in medspa
• North America held the largest revenue share in 2021 owing to rapid advancement in the aesthetic devices sector by key players and growing R&D activities in aesthetics

Access Press Release@ https://www.grandviewresearch.com/press-release/global-energy-based-aesthetic-devices-market

Energy-based Aesthetic Devices Market Segmentation

Grand View Research has segmented the global energy-based aesthetic devices market on the basis of application, end-use, and region:

Energy-based Aesthetic Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Body Contouring & Skin Tightening
• Skin Rejuvenation
  • Wrinkles
  • Acne & Other Scars
  • Skin Pigmentation
  • Aging
• Hair Removal
• Leg Vein Treatment
• Vaginal Rejuvenation
• Pigmented Lesion & Tattoo Removal
• Others

Energy-based Aesthetic Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital/Surgery Center
• Medspa
• Traditional Spa
• HCP Owned Clinic

Energy-based Aesthetic Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Energy-based Aesthetic Devices Market

• Syneron Medical Ltd.
• Merz Pharma GmbH & Co. KGaA
• Lumenis Ltd.
• Alma Lasers Inc.
• Zeltiq
• En.
• Cutera
• Sisram
• Allergan Plc
• Cynosure

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.